These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 27626167)
1. Prognostic significance of osteopontin expression in gastric cancer: a meta-analysis. Gu X; Gao XS; Ma M; Qin S; Qi X; Li X; Sun S; Yu H; Wang W; Zhou D Oncotarget; 2016 Oct; 7(43):69666-69673. PubMed ID: 27626167 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of osteopontin in hepatocellular carcinoma: a meta-analysis. Zhang CH; Xu GL; Jia WD; Ge YS; Li JS; Ma JL; Ren WH Int J Cancer; 2012 Jun; 130(11):2685-92. PubMed ID: 21780114 [TBL] [Abstract][Full Text] [Related]
3. Elevated plasma osteopontin associated with gastric cancer development, invasion and survival. Wu CY; Wu MS; Chiang EP; Wu CC; Chen YJ; Chen CJ; Chi NH; Chen GH; Lin JT Gut; 2007 Jun; 56(6):782-9. PubMed ID: 17148500 [TBL] [Abstract][Full Text] [Related]
4. Prognostic and clinicopathological value of osteopontin expression in non-small cell lung cancer: a meta-analysis and systematic review. Song Y; Li H; Jiang Q; Wu L Biomarkers; 2024 Mar; 29(2):105-113. PubMed ID: 38376506 [TBL] [Abstract][Full Text] [Related]
5. Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer. Rouanne M; Adam J; Goubar A; Robin A; Ohana C; Louvet E; Cormier J; Mercier O; Dorfmüller P; Fattal S; de Montpreville VT; Lebret T; Dartevelle P; Fadel E; Besse B; Olaussen KA; Auclair C; Soria JC BMC Cancer; 2016 Jul; 16():483. PubMed ID: 27422280 [TBL] [Abstract][Full Text] [Related]
6. Expression of osteopontin and CDX2: indications of phenotypes and prognosis in advanced gastric cancer. Zhang X; Tsukamoto T; Mizoshita T; Ban H; Suzuki H; Toyoda T; Tatematsu M Oncol Rep; 2009 Mar; 21(3):609-13. PubMed ID: 19212618 [TBL] [Abstract][Full Text] [Related]
7. [Expression of osteopontin splice variant and its clinical significance in gastric cancer]. Sun X; Wang L; Hou W; Li Y; Liu L; Zuo W; Yu J Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):427-30. PubMed ID: 26463145 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic value of preoperative plasma fibrinogen in gastric cancer patients: A meta-analysis. Cheng F; Zeng C; Zeng L; Chen Y Medicine (Baltimore); 2019 Oct; 98(40):e17310. PubMed ID: 31577724 [TBL] [Abstract][Full Text] [Related]
9. The impact of osteopontin on prognosis and clinicopathology of colorectal cancer patients: a systematic meta-analysis. Zhao M; Liang F; Zhang B; Yan W; Zhang J Sci Rep; 2015 Aug; 5():12713. PubMed ID: 26234583 [TBL] [Abstract][Full Text] [Related]
10. Vimentin immunohistochemical expression as a prognostic factor in gastric cancer: A meta-analysis. Yin S; Chen FF; Yang GF Pathol Res Pract; 2018 Sep; 214(9):1376-1380. PubMed ID: 30078472 [TBL] [Abstract][Full Text] [Related]
11. The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: A meta-analysis. Yang Y; Gao P; Song Y; Sun J; Chen X; Zhao J; Ma B; Wang Z Eur J Surg Oncol; 2016 Aug; 42(8):1176-82. PubMed ID: 27293109 [TBL] [Abstract][Full Text] [Related]
12. Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer. Cao GD; Xu XY; Zhang JW; Chen B; Xiong MM PLoS One; 2016; 11(12):e0168085. PubMed ID: 28005970 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and prognostic significance of osteopontin expression in patients with prostate cancer: a systematic review and meta-analysis. Yu A; Guo K; Qin Q; Xing C; Zu X Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 33635319 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of osteopontin in patients with hepatocellular carcinoma: A systematic review and meta-analysis. Sun T; Li P; Sun D; Bu Q; Li G Medicine (Baltimore); 2018 Oct; 97(43):e12954. PubMed ID: 30412113 [TBL] [Abstract][Full Text] [Related]
15. Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection. Chen RX; Xia YH; Cui JF; Xue TC; Ye SL J Gastroenterol Hepatol; 2010 Aug; 25(8):1435-42. PubMed ID: 20659235 [TBL] [Abstract][Full Text] [Related]
16. Distinctive Prognostic Value and Cellular Functions of Osteopontin Splice Variants in Human Gastric Cancer. Hao C; Cui Y; Lane J; Jia S; Ji J; Jiang WG Cells; 2021 Jul; 10(7):. PubMed ID: 34359989 [TBL] [Abstract][Full Text] [Related]
17. The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression. Lin CN; Wang CJ; Chao YJ; Lai MD; Shan YS BMC Cancer; 2015 Mar; 15():128. PubMed ID: 25872762 [TBL] [Abstract][Full Text] [Related]
18. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer. Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of the RUNX3 expression in gastric cancer: a systematic review and meta-analysis. Liu B; Han Y; Jiang L; Jiang D; Li W; Zhang T; Zu G; Zhang X Int J Surg; 2018 May; 53():122-128. PubMed ID: 29578091 [TBL] [Abstract][Full Text] [Related]
20. Bcl-2 expression and patient survival in gastric cancer: a systematic review of the literature with meta-analysis. Cheng H; Wang X; Li T; Chen L Med Oncol; 2015 Jan; 32(1):389. PubMed ID: 25428392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]